Psoriasis

Beyond the traditional approach

At Ignite Biomedical, we're revolutionizing the approach to psoriasis treatment through our cutting-edge precision medicine solutions. While many effective biologics exist for treating psoriasis, we recognize there's still an unmet need for certain patient populations. That's why we're leading the way with our innovative Treatment Response Predictors (TRPs).

Our flagship product, the TNF-alpha inhibitor Treatment Response Predictor, has recently achieved a key milestone with successful analytical validation. This groundbreaking tool has the potential to transform care for patients with plaque psoriasis by identifying those most likely to benefit from TNF-alpha inhibitor therapy.

We understand that approximately 70% of patients currently don't respond to TNF inhibitor treatments. Our TRP aims to change that by:

• Reducing unnecessary risks and costs associated with ineffective treatments
• Improving outcomes for responsive patients
• Ensuring each patient receives the right treatment at the right time

By leveraging Emerge® AI platform from Liquid Bioscience, we're developing precision biomarkers that go beyond traditional approaches. Our goal is to provide clinicians with objective, data-driven decision support tools that can revolutionize psoriasis management.

At Ignite Biomedical, we're not just developing tests; we're pioneering a patient-focused approach to managing psoriasis. Our commitment to precision medicine means we're working tirelessly to ensure every patient receives personalized, effective care that improves their quality of life.

What is plaque psoriasis?

Plaque psoriasis is the most common form of psoriasis, affecting 80-90% of people with the condition. It is an autoimmune disease that causes raised, inflamed, and scaly patches of skin called plaques. These plaques are often itchy, painful, or both and can appear on the scalp, elbows, knees, lower back, and other areas. On lighter skin tones, plaques are typically red with silvery-white scales, while on darker skin tones, they may appear purple, grayish, or dark brown. The condition is chronic and can significantly impact quality of life due to discomfort and visible symptoms